Pharmaceutical Composition Exhibiting Anti-Tumor Activity, Method for Treating Patient Suffering From Cancer and Method for Inhibiting Tumor Growth
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- GONGWIN BIOPHARM CO., LTD., Taipei, Taiwan has been assigned a patent (No. US 12144789 B2, initially filed Jan. 19, 2022) developed by five inventors Nanshan Zhong, Guangzhou, China; Longjiang Li, Chengdu, China; Chia-Shun Shih, Taipei, Taiwan; Lester J. Wu, Cape Coral, Florida; and Mao-Yuan Lin, Taipei, Taiwan, for "Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth . . .